Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy

Completed · Phase 3 · Has a placebo group

Conditions studied: Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Sulfasalazine may relieve diarrhea in patients with cancer who are undergoing pelvic radiation therapy. PURPOSE: This randomized phase III trial is studying sulfasalazine to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation therapy.

Key facts

Study ID
NCT01198145
Run by
Alliance for Clinical Trials in Oncology
People needed
87
Starts
2011-04-01
Expected to finish
2017-07-15
Last updated by the study team
2020-05-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.